RxDoctor Payments Data

Phillip Johnson, MD

Family Medicine · Litchfield, ILNPI 1225089683

Payments from drug & device makers

$5,172in general payments, 2019–2025

Across 286 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$742
  • Lilly USA, LLC$695
  • Pfizer$512
  • Novo Nordisk$337
  • Otsuka America Pharmaceutical, Inc.$226
  • Novartis$217
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$5,04197%
  • Education$651%
  • Other$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,172 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$25,629
Medicare patients
119
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban499$258,169
TrulicityDulaglutide168$173,089
OzempicSemaglutide115$136,950
JardianceEmpagliflozin217$127,239
MounjaroTirzepatide86$99,445
IngrezzaValbenazine Tosylate25$91,469
XareltoRivaroxaban84$62,652
EntrestoSacubitril/Valsartan84$39,522
MyrbetriqMirabegron61$30,773
VraylarCariprazine Hcl18$27,661
JanuviaSitagliptin Phosphate42$27,530
Tresiba Flextouch U-200Insulin Degludec20$27,204
Lurasidone Hcl40$26,996
FarxigaDapagliflozin Propanediol41$25,249
CaplytaLumateperone Tosylate27$22,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$695$272,534254 claims
PfizerEliquis, Premarin$512$265,926518 claims
Novo NordiskOzempic, Fiasp$337$149,209140 claims
Boehringer IngelheimJardiance, Tradjenta$154$137,158228 claims
Neurocrine Biosciences, Inc.Ingrezza$190$91,46925 claims
Johnson & JohnsonXarelto, Risperdal Consta$74$79,62495 claims
GSKBreo Ellipta, Incruse Ellipta, Trelegy Ellipta, Arexvy, Arnuity Ellipta$146$68,355164 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$121$42,25593 claims
NovartisEntresto$217$39,52284 claims
Astellas Pharma US IncMyrbetriq$29$30,77361 claims
AbbVieVraylar$742$27,66118 claims
MerckJanuvia$35$27,53042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Litchfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →